会上管理层介绍，上半年，公司新医疗战略稳步推进，截至2025年7月底，公司诊所会员店超2,400家， 计划三年内实现万家诊所联盟。公司旗下九医诊所公司主要以供应链业务为基础，聚焦全国诊所"产品 推广+会员联盟"，最终目标走向"医疗服务+供应链"融合的业务模式。 其中，在品种满足率方面，公司在已有供应链品种的基础上，不断引入诊所专销品种，完善诊所品种结 构，并与太极、华润三九、长风药业、吉林敖东、津药药业等多个上游厂家达成合作，上半年新品引入 超260个。 在数字化赋能方面，公司自主研发并上线九医SaaS诊所管家系统，为诊所客户提供数智化运营增值服 务，可实现3秒建档、10秒出方、医保结算、营收分析以及药品追溯码、5秒入库、效期预警等，目前 1,525家诊所会员店已上线使用该系统； 9月3日，九州通举办2025半年度业绩说明会。会上有投资者询问公司在AI技术应用方面的进展。对 此，管理层回应，公司积极拥抱 AI 人工智能技术，通过自主研发以及与阿里云、腾讯云等头部企业合 作等方式，开发针对不同应用场景的 AI 智能体，加速业务及管理的数智化转型。 目前，公司以 AI 技术、大模型为基础，结合自身业务及管理体系， ...

Core Insights - The private economy in Wuhan has surpassed 1 trillion yuan, reaching 1.02 trillion yuan in 2024, marking a significant milestone for the region [1] - The top three private enterprises in Hubei, including Jiuzhoutong Pharmaceutical Group and Hengxin Automobile Group, are located near Longyang Lake, contributing to a high concentration of private enterprises in the area [1][2] - Over the past five years, the Longyang Lake area has developed into a 100 billion yuan private economic belt, with Jiuzhoutong's revenue exceeding 150 billion yuan and Hengxin's surpassing 80 billion yuan in 2024 [1][5] Company and Industry Summaries - Jiuzhoutong has grown from 41.1 billion yuan in revenue in 2014 to 151.81 billion yuan in 2024, demonstrating significant growth as a "chain leader" in the health sector [4][11] - The Jiuzhoutong Health City has achieved over 95% occupancy within two years, housing 148 enterprises across various sectors, including health, finance, and software development [4] - Hengxin Automobile Group has established itself as a leading player in the automotive sector, contributing to a nearly 100 billion yuan automotive sales cluster in the region [5][11] - The Longyang Lake area has attracted 1.1 million enterprises, with over 99% being private, reflecting an 88% increase since 2020 [2] - The innovation ecosystem in the Longyang Lake area has fostered the growth of various industries, including health, automotive, technology, and cultural tourism, creating a closed-loop economy [10][12] - Jiuzhoutong's digital transformation has led to 1.25159 billion yuan in revenue from digital pharmaceutical distribution and supply chain services, highlighting the importance of innovation in driving growth [11] - The establishment of the AI Medical Innovation Unit in collaboration with Han Yang Technology Innovation Research Institute has resulted in a 90% increase in revenue for companies like Xingxue Data [10][11]